Compare GL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GL | ICLR |
|---|---|---|
| Founded | 1900 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.1B |
| IPO Year | 1998 | 2001 |
| Metric | GL | ICLR |
|---|---|---|
| Price | $154.42 | $185.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $193.18 | $187.76 |
| AVG Volume (30 Days) | 419.2K | ★ 858.3K |
| Earning Date | 10-21-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | ★ 17.84 | N/A |
| EPS | ★ 7.04 | N/A |
| Revenue | ★ $5,994,318,000.00 | N/A |
| Revenue This Year | $6.63 | N/A |
| Revenue Next Year | $5.95 | $3.63 |
| P/E Ratio | $23.90 | ★ $12.91 |
| Revenue Growth | ★ 3.74 | N/A |
| 52 Week Low | $127.85 | $66.57 |
| 52 Week High | $191.55 | $203.91 |
| Indicator | GL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 25.52 | 63.96 |
| Support Level | $148.25 | $157.92 |
| Resistance Level | $155.60 | $191.00 |
| Average True Range (ATR) | 3.76 | 8.68 |
| MACD | -0.27 | 2.16 |
| Stochastic Oscillator | 2.02 | 81.23 |
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.